Biomed Pharmacother 108:952962
However, these findings are relatively rare
Novos diabetes and weight-loss molecule went off patent on March 21, paving the way for a raft of lower-priced generics from Indian drugmakers including Sun Pharma, Torrent, Zydus, Dr Reddys Laboratories, Glenmark, Natco, and Eris
Specifically designed to convert stored fat into energy, which can contribute to increased physical performance and weight reduction
Some may experience mild digestive discomfort at higher doses
When you pay $1,349 per month for Wegovy, you're partly paying for the decade of clinical trials that established its safety and efficacy in studied populations, the FDA premarket review that verified those studies, the standardized manufacturing that guarantees dose consistency from vial to vial, and the ongoing pharmacovigilance that monitors real-world adverse events